Kyle Rose
Stock Analyst at Canaccord Genuity
(2.58)
# 2,176
Out of 5,241 analysts
113
Total ratings
51.06%
Success rate
12.61%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $435 → $400 | $306.76 | +30.40% | 21 | May 1, 2026 | |
| PODD Insulet | Maintains: Buy | $432 → $450 | $147.46 | +205.17% | 17 | Dec 17, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $29.54 | -8.60% | 6 | Feb 26, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $76.64 | -7.36% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $24.29 | +192.30% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $13.90 | +58.27% | 10 | Oct 13, 2023 | |
| SKIN SkinHealth Systems | Assumes: Buy | $10 | $0.64 | +1,453.52% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $7.66 | +187.21% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $61.63 | +143.39% | 17 | Jul 28, 2023 | |
| SIBN SI-BONE | Maintains: Buy | $24 → $27 | $14.16 | +90.68% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.91 | +1,557.46% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $40.99 | -63.41% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $154.36 | -20.96% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $3.90 | +2.56% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $10.58 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $83.70 | +49.34% | 7 | Feb 8, 2022 |
Stryker
May 1, 2026
Maintains: Buy
Price Target: $435 → $400
Current: $306.76
Upside: +30.40%
Insulet
Dec 17, 2025
Maintains: Buy
Price Target: $432 → $450
Current: $147.46
Upside: +205.17%
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $29.54
Upside: -8.60%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $76.64
Upside: -7.36%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $24.29
Upside: +192.30%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $13.90
Upside: +58.27%
SkinHealth Systems
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $0.64
Upside: +1,453.52%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $7.66
Upside: +187.21%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $61.63
Upside: +143.39%
SI-BONE
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $14.16
Upside: +90.68%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $0.91
Upside: +1,557.46%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $40.99
Upside: -63.41%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $154.36
Upside: -20.96%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $3.90
Upside: +2.56%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $10.58
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $83.70
Upside: +49.34%